Moutih Rafei
Chief Tech/Sci/R&D Officer bei DEFENCE THERAPEUTICS INC.
Vermögen: 87 500 $ am 31.03.2024
Profil
Moutih Rafei is the founder of Axiom Services, Inc., IntelliStem Technologies, Inc. He is currently working as the Chief Scientific Officer & Director at Defence Therapeutics Inc. Additionally, he holds the position of Professor & Principal Investigator at the University of Montréal.
Dr. Rafei obtained his doctorate degree from McGill University in 2009.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
02.11.2023 | 70 000 ( 0,16% ) | 87 500 $ | 31.03.2024 |
Aktive Positionen von Moutih Rafei
Unternehmen | Position | Beginn |
---|---|---|
DEFENCE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 09.10.2020 |
University of Montréal | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Moutih Rafei
Unternehmen | Position | Ende |
---|---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Founder | 01.08.2023 |
Ausbildung von Moutih Rafei
McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
IntelliStem Technologies, Inc.
IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |